Mounjaro Pens – Higher Dose

You may only purchase this item as an existing patient who has been consulted and assessed by the nurse at Lioness Medical.

Mounjaro® contains an FDA approved medication called Tirzepatide.

Tirzepatide is licenced to treat type-2 diabetes and obesity.

Mounjaro pens contain four weekly doses for subcutaneous injection as per instructions within.

It is a simple injection pen which is self-administered weekly, and pre-filled with the medication. You will also be supplied with the required needles and a sharps bin for disposal of the needles.